Literature DB >> 10604991

Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4.

A Lorentz1, S Schwengberg, G Sellge, M P Manns, S C Bischoff.   

Abstract

Mast cells are recognized as a new type of immunoregulatory cells capable of producing different cytokines. So far, little is known about the cytokine profile of mature human mast cells isolated from intestinal tissue and cultured in the presence of stem cell factor (SCF). We observed that these cells express the proinflammatory cytokines TNF-alpha, IL-1 beta, IL-6, IL-8, IL-16, and IL-18 without further stimulation. Both IgE-dependent and IgE-independent agonists (e.g., Gram-negative bacteria) enhanced expression of TNF-alpha. Another set of cytokines consisting of IL-3, IL-5, IL-9, and IL-13 was expressed following activation by IgE receptor cross-linking. If mast cells were cultured in the presence of IL-4 and SCF, the production and release of IL-3, IL-5, and IL-13 was increased up to 4-fold compared with mast cells cultured with SCF alone. By contrast, IL-6 expression was completely blocked in response to culture with IL-4. In summary, our data show that mature human mast cells produce proinflammatory cytokines that may be up-regulated following triggering with IgE-independent agonists such as bacteria, whereas activation by IgE receptor cross-linking results in the expression of Th2-type cytokines. IL-4 enhances the expression of Th2-type cytokines but does not affect or even down-regulates proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10604991     DOI: 10.4049/jimmunol.164.1.43

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production.

Authors:  H Ochi; N H De Jesus; F H Hsieh; K F Austen; J A Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 2.  Leukocytes in glomerular injury.

Authors:  Stephen R Holdsworth; Peter G Tipping
Journal:  Semin Immunopathol       Date:  2007-10-16       Impact factor: 9.623

Review 3.  Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases.

Authors:  Oliver T Burton; Hans C Oettgen
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

4.  Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells.

Authors:  Eun-Ju Lee; Geun-Eok Ji; Mi-Kyung Sung
Journal:  Inflamm Res       Date:  2010-04-13       Impact factor: 4.575

Review 5.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

6.  Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.

Authors:  Oliver T Burton; Jaciel M Tamayo; Amanda J Stranks; Kyle J Koleoglou; Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

7.  Anti-allergic effects of ethanol extracts from brown seaweeds.

Authors:  Haider Samee; Zhen-xing Li; Hong Lin; Jamil Khalid; Yong-chao Guo
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

8.  IL-33 is produced by mast cells and regulates IgE-dependent inflammation.

Authors:  Chia-Lin Hsu; Colleen V Neilsen; Paul J Bryce
Journal:  PLoS One       Date:  2010-08-03       Impact factor: 3.240

9.  Chronic intestinal nematode infection induces Stat6-independent interleukin-5 production and causes eosinophilic inflammatory responses in mice.

Authors:  Yukiko Sakamoto; Kenji Hiromatsu; Kenji Ishiwata; Kyoko Inagaki-Ohara; Takuto Ikeda; Fukumi Nakamura-Uchiyama; Yukifumi Nawa
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 10.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.